【摘要】 肥胖、糖尿病、心血管疾病和慢性肾脏病常多病共存，严重危害人类健康，已经成为我国重大公共卫生问题。目前，针对多病共存患者的临床诊疗仍缺乏有效的多学科协作。美国心脏协会发布了关于心血管-肾脏-代谢（cardiovascular-kidney-metabolic,CKM）综合征的主席建议，旨在加强共病患者的多学科协同管理。本共识基于国内外相关临床研究证据，同时借鉴和参考相关领域的临床指南，总结了CKM综合征流行病学、生理和病理生理机制、各分期特征、筛查、风险评估、临床管理和治疗路径、生活方式医学管理、社区慢病管理，公共卫生预防政策和患者教育等内容，旨在提高我国医务人员对CKM的诊疗能力和慢病管理水平，进一步改善我国CKM综合征患者的预后。更多还原

【Abstract】 Obesity, diabetes, cardiovascular disease and chronic kidney disease often coexist, which seriously endangers human health and has become a major public health problem in China. At present, there is still a lack of effective interdisciplinary collaboration in clinical diagnosis and treatment for patients with multiple diseases coexisting simultaneously. The American Heart Association has released a presidential advisory on cardiovascular-kidney-metabolic (CKM) syndrome, aimed at strengthening multidisciplinary collaborative management of comorbidities. The expert consensus is based on relevant clinical research evidence at home and abroad, while drawing on and referring to clinical guidelines in related fields. It summarizes the epidemiology,physiological and pathophysiological mechanisms, staging characteristics, screening, risk assessment, clinical management and treatment pathways of CKM syndrome, lifestyle medical management, community chronic disease management, public health prevention policies, and patient education. We aim to enhance the diagnostic and treatment capabilities of medical personnel in China regarding CKM syndrome, as well as the management level of chronic diseases, in order to further improve the prognosis of patients in China.更多还原